Correlation Between Erasca and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Erasca and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erasca and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erasca Inc and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Erasca and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erasca with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erasca and Acrivon Therapeutics,.
Diversification Opportunities for Erasca and Acrivon Therapeutics,
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Erasca and Acrivon is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Erasca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erasca Inc are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Erasca i.e., Erasca and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Erasca and Acrivon Therapeutics,
Given the investment horizon of 90 days Erasca Inc is expected to under-perform the Acrivon Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Erasca Inc is 1.41 times less risky than Acrivon Therapeutics,. The stock trades about -0.02 of its potential returns per unit of risk. The Acrivon Therapeutics, Common is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,253 in Acrivon Therapeutics, Common on August 25, 2024 and sell it today you would lose (598.00) from holding Acrivon Therapeutics, Common or give up 47.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Erasca Inc vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Erasca Inc |
| Acrivon Therapeutics, |
Erasca and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Erasca and Acrivon Therapeutics,
The main advantage of trading using opposite Erasca and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erasca position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Erasca vs. Eliem Therapeutics | Erasca vs. HCW Biologics | Erasca vs. RenovoRx | Erasca vs. Tempest Therapeutics |
| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. RenovoRx | Acrivon Therapeutics, vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |